vs
Progyny, Inc.（PGNY）とBRC Group Holdings, Inc.（RILY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Progyny, Inc.の直近四半期売上が大きい（$318.4M vs $188.3M、BRC Group Holdings, Inc.の約1.7倍）。BRC Group Holdings, Inc.の純利益率が高く（47.9% vs 3.9%、差は44.0%）。Progyny, Inc.の前年同期比売上増加率が高い（6.7% vs -21.9%）。過去8四半期でProgyny, Inc.の売上複合成長率が高い（7.0% vs -15.4%）
Progyny, Inc.は米国を中心に事業を展開する有力な不妊治療・家族形成支援福利厚生サービスプロバイダーです。企業顧客と提携し、体外受精、妊孕性温存、養子縁組支援、代理出産サポートなどの福利厚生を提供し、多様な業種の従業員にサービスを届けています。
PGNY vs RILY — 直接比較
売上が大きい
PGNY
1.7倍大きい
$188.3M
売上成長率が高い
PGNY
+28.6%の差
-21.9%
純利益率が高い
RILY
純利益率が44.0%高い
3.9%
2年売上CAGRが高い
PGNY
2年複合成長率
-15.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $318.4M | $188.3M |
| 純利益 | $12.5M | $90.3M |
| 粗利率 | 24.1% | 79.5% |
| 営業利益率 | 4.8% | 32.3% |
| 純利益率 | 3.9% | 47.9% |
| 売上前年比 | 6.7% | -21.9% |
| 純利益前年比 | 18.5% | 1710.8% |
| EPS（希薄化後） | $0.14 | $2.78 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上PGNYRILY
| Q4 25 | $318.4M | $188.3M | ||
| Q3 25 | $313.3M | $215.3M | ||
| Q2 25 | $332.9M | $188.2M | ||
| Q1 25 | $324.0M | $197.2M | ||
| Q4 24 | $298.4M | $241.0M | ||
| Q3 24 | $286.6M | $225.5M | ||
| Q2 24 | $304.1M | $256.0M | ||
| Q1 24 | $278.1M | $263.4M |
純利益PGNYRILY
| Q4 25 | $12.5M | $90.3M | ||
| Q3 25 | $13.9M | $91.1M | ||
| Q2 25 | $17.1M | $139.5M | ||
| Q1 25 | $15.1M | $-10.0M | ||
| Q4 24 | $10.5M | $-5.6M | ||
| Q3 24 | $10.4M | $-284.4M | ||
| Q2 24 | $16.5M | $-433.6M | ||
| Q1 24 | $16.9M | $-49.2M |
粗利率PGNYRILY
| Q4 25 | 24.1% | 79.5% | ||
| Q3 25 | 23.2% | 83.7% | ||
| Q2 25 | 23.7% | 81.3% | ||
| Q1 25 | 23.4% | 81.4% | ||
| Q4 24 | 21.3% | 79.8% | ||
| Q3 24 | 20.7% | 82.1% | ||
| Q2 24 | 22.5% | 84.5% | ||
| Q1 24 | 22.4% | 85.3% |
営業利益率PGNYRILY
| Q4 25 | 4.8% | 32.3% | ||
| Q3 25 | 6.9% | 30.4% | ||
| Q2 25 | 7.3% | 5.7% | ||
| Q1 25 | 7.5% | -31.2% | ||
| Q4 24 | 5.3% | -69.2% | ||
| Q3 24 | 4.3% | -36.4% | ||
| Q2 24 | 6.8% | -90.8% | ||
| Q1 24 | 6.7% | -6.1% |
純利益率PGNYRILY
| Q4 25 | 3.9% | 47.9% | ||
| Q3 25 | 4.4% | 42.3% | ||
| Q2 25 | 5.1% | 74.1% | ||
| Q1 25 | 4.6% | -5.1% | ||
| Q4 24 | 3.5% | -2.3% | ||
| Q3 24 | 3.6% | -126.1% | ||
| Q2 24 | 5.4% | -169.4% | ||
| Q1 24 | 6.1% | -18.7% |
EPS（希薄化後）PGNYRILY
| Q4 25 | $0.14 | $2.78 | ||
| Q3 25 | $0.15 | $2.91 | ||
| Q2 25 | $0.19 | $4.50 | ||
| Q1 25 | $0.17 | $-0.39 | ||
| Q4 24 | $0.12 | $-0.01 | ||
| Q3 24 | $0.11 | $-9.39 | ||
| Q2 24 | $0.17 | $-14.35 | ||
| Q1 24 | $0.17 | $-1.71 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $112.2M | $226.6M |
| 総負債低いほど良い | — | $1.4B |
| 株主資本純資産 | $516.0M | $-171.5M |
| 総資産 | $742.4M | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資PGNYRILY
| Q4 25 | $112.2M | $226.6M | ||
| Q3 25 | $134.0M | $184.2M | ||
| Q2 25 | $132.5M | $267.4M | ||
| Q1 25 | $109.2M | $138.3M | ||
| Q4 24 | $162.3M | $146.9M | ||
| Q3 24 | $91.5M | $159.2M | ||
| Q2 24 | $95.0M | $236.9M | ||
| Q1 24 | $115.0M | $190.7M |
総負債PGNYRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
株主資本PGNYRILY
| Q4 25 | $516.0M | $-171.5M | ||
| Q3 25 | $560.0M | $-260.5M | ||
| Q2 25 | $515.0M | $-351.7M | ||
| Q1 25 | $467.2M | $-496.8M | ||
| Q4 24 | $422.1M | $-488.2M | ||
| Q3 24 | $434.9M | $-497.6M | ||
| Q2 24 | $456.2M | $-218.3M | ||
| Q1 24 | $571.6M | $228.4M |
総資産PGNYRILY
| Q4 25 | $742.4M | $1.7B | ||
| Q3 25 | $795.2M | $1.7B | ||
| Q2 25 | $761.0M | $1.5B | ||
| Q1 25 | $730.3M | $1.5B | ||
| Q4 24 | $607.1M | $1.8B | ||
| Q3 24 | $660.0M | $2.2B | ||
| Q2 24 | $698.6M | $3.2B | ||
| Q1 24 | $794.3M | $5.0B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $54.2M | $26.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $48.6M | — |
| FCFマージンFCF / 売上 | 15.3% | — |
| 設備投資強度設備投資 / 売上 | 1.8% | — |
| キャッシュ転換率営業CF / 純利益 | 4.34× | 0.29× |
| 直近12ヶ月FCF直近4四半期 | $191.8M | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローPGNYRILY
| Q4 25 | $54.2M | $26.2M | ||
| Q3 25 | $50.7M | $-60.6M | ||
| Q2 25 | $55.5M | $-25.6M | ||
| Q1 25 | $49.8M | $184.0K | ||
| Q4 24 | $52.2M | $-2.7M | ||
| Q3 24 | $44.5M | $19.5M | ||
| Q2 24 | $56.7M | $111.5M | ||
| Q1 24 | $25.7M | $135.4M |
フリーキャッシュフローPGNYRILY
| Q4 25 | $48.6M | — | ||
| Q3 25 | $46.0M | — | ||
| Q2 25 | $50.2M | — | ||
| Q1 25 | $47.0M | — | ||
| Q4 24 | $50.3M | — | ||
| Q3 24 | $42.7M | — | ||
| Q2 24 | $55.8M | — | ||
| Q1 24 | $24.9M | — |
FCFマージンPGNYRILY
| Q4 25 | 15.3% | — | ||
| Q3 25 | 14.7% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 18.4% | — | ||
| Q1 24 | 8.9% | — |
設備投資強度PGNYRILY
| Q4 25 | 1.8% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
キャッシュ転換率PGNYRILY
| Q4 25 | 4.34× | 0.29× | ||
| Q3 25 | 3.65× | -0.66× | ||
| Q2 25 | 3.24× | -0.18× | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 1.52× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
